CA1301002C - Methode et dispositif de perfusion retrograde servant a traiter une maladieou un immunodeficit - Google Patents
Methode et dispositif de perfusion retrograde servant a traiter une maladieou un immunodeficitInfo
- Publication number
- CA1301002C CA1301002C CA000554813A CA554813A CA1301002C CA 1301002 C CA1301002 C CA 1301002C CA 000554813 A CA000554813 A CA 000554813A CA 554813 A CA554813 A CA 554813A CA 1301002 C CA1301002 C CA 1301002C
- Authority
- CA
- Canada
- Prior art keywords
- tumor
- catheter
- perfusion
- patient
- chemotherapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000010412 perfusion Effects 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title abstract description 32
- 230000007812 deficiency Effects 0.000 title abstract description 3
- 201000010099 disease Diseases 0.000 title abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 3
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 76
- 239000002246 antineoplastic agent Substances 0.000 claims abstract description 17
- 229940127089 cytotoxic agent Drugs 0.000 claims abstract description 17
- 238000001802 infusion Methods 0.000 claims abstract description 17
- 210000003462 vein Anatomy 0.000 claims description 16
- 239000012530 fluid Substances 0.000 claims description 11
- 238000002347 injection Methods 0.000 claims description 8
- 239000007924 injection Substances 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 2
- 238000002512 chemotherapy Methods 0.000 abstract description 14
- 239000003814 drug Substances 0.000 abstract description 13
- 229940079593 drug Drugs 0.000 abstract description 10
- 231100000057 systemic toxicity Toxicity 0.000 abstract description 10
- 210000000056 organ Anatomy 0.000 abstract description 7
- 238000001727 in vivo Methods 0.000 abstract description 6
- 230000002792 vascular Effects 0.000 abstract description 6
- 230000001276 controlling effect Effects 0.000 abstract description 4
- 238000012544 monitoring process Methods 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 description 17
- 210000005166 vasculature Anatomy 0.000 description 15
- 230000017531 blood circulation Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 231100000673 dose–response relationship Toxicity 0.000 description 4
- 230000001771 impaired effect Effects 0.000 description 4
- 210000000264 venule Anatomy 0.000 description 4
- 206010061309 Neoplasm progression Diseases 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 230000005751 tumor progression Effects 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000000973 chemotherapeutic effect Effects 0.000 description 2
- 230000010102 embolization Effects 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 210000003191 femoral vein Anatomy 0.000 description 2
- 230000003284 homeostatic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 210000002796 renal vein Anatomy 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000008321 arterial blood flow Effects 0.000 description 1
- 230000010108 arterial embolization Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000010109 chemoembolization Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000010429 evolutionary process Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000009650 gentamicin protection assay Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 229940124452 immunizing agent Drugs 0.000 description 1
- 239000000677 immunologic agent Substances 0.000 description 1
- 229940124541 immunological agent Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 239000002534 radiation-sensitizing agent Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 231100000901 systemic toxic effect Toxicity 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000554813A CA1301002C (fr) | 1987-12-18 | 1987-12-18 | Methode et dispositif de perfusion retrograde servant a traiter une maladieou un immunodeficit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000554813A CA1301002C (fr) | 1987-12-18 | 1987-12-18 | Methode et dispositif de perfusion retrograde servant a traiter une maladieou un immunodeficit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1301002C true CA1301002C (fr) | 1992-05-19 |
Family
ID=4137104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000554813A Expired - Lifetime CA1301002C (fr) | 1987-12-18 | 1987-12-18 | Methode et dispositif de perfusion retrograde servant a traiter une maladieou un immunodeficit |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1301002C (fr) |
-
1987
- 1987-12-18 CA CA000554813A patent/CA1301002C/fr not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4714460A (en) | Methods and systems for retrograde perfusion in the body for curing it of the disease or immume deficiency | |
| US4867742A (en) | Retrograde perfusion | |
| US4883459A (en) | Retrograde perfusion | |
| EP0321614B1 (fr) | Système de rétroperfusion du corps pour le guérir d'une maladie ou d'une déficience immunitaire | |
| EP2819722B1 (fr) | Système de contrôle et de surveillance de la perfusion sanguine d'un organe | |
| EP1202759B1 (fr) | Systeme de perfusion | |
| US5186713A (en) | Extracorporeal blood oxygenation system and method for providing hemoperfusion during transluminal balloon angioplasty procedures | |
| US7363072B2 (en) | Method and apparatus to remove substances from vessels of the heart and other parts of the body to minimize or avoid renal or other harm or dysfunction | |
| JP3650122B2 (ja) | 心臓停止カテーテルシステム | |
| US7824357B2 (en) | Method and system for preventing contrast associated nephropathy | |
| US4447236A (en) | Infusion catheter system | |
| JP4224608B2 (ja) | 注入療法用装置 | |
| US20020107504A1 (en) | Apparatus for local drug delivery in limb | |
| US6682499B2 (en) | Method and apparatus for venous drainage and retrograde coronary perfusion | |
| JP2006520649A5 (ja) | 輸出生理液集合部位から薬剤を回収するための方法および装置 | |
| US20020077581A1 (en) | Simplified cerebral retroperfusion apparatus and method | |
| KR20010052377A (ko) | 치료용 물질을 압력 조절에 의해 선택적으로 전달시키는방법 및 캐뉼라 | |
| WO1999004849A1 (fr) | Catheter de retroperfusion et procede associe | |
| WO1991008791A1 (fr) | Catheter d'angiographie a passages multiples | |
| US20090221949A1 (en) | Device and method for circulatory isolation and treatment of a part of a body | |
| CA1301002C (fr) | Methode et dispositif de perfusion retrograde servant a traiter une maladieou un immunodeficit | |
| US6641572B2 (en) | Interstitial space saturation | |
| JP2650932B2 (ja) | 体内の腫瘍治療用カテーテル装置 | |
| CN111166426B (zh) | 一种适用于静脉溶栓禁忌症的局部溶栓取栓装置及其使用方法 | |
| WO2000029046A2 (fr) | Systeme de perfusion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed | ||
| MKEC | Expiry (correction) |
Effective date: 20121205 |